Androgen Receptor in Breast Cancer: From Bench to Bedside

Overview of attention for article published in Frontiers in endocrinology, September 2020

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Above-average Attention Score compared to outputs of the same age and source (60th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 34 Dimensions

Readers on

mendeley: 68 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 15,745 followers.

@silke4senate This article does a good job of pulling together different perspectives: https://t.co/gN2wyrnM6p

04 Apr 2022

Reply Repost Favourite

RT @tkdmHawkeye: TN乳癌でARのamplificationがある場合の治療選択肢について先週から悶々と考えていたのだけれども、一応最新のレビューではARはどちらかというと予後良好因子でER陽性症例ではERと競合することになってる https://t.co/CX…

07 Oct 2020

Reply Repost Favourite

TN乳癌でARのamplificationがある場合の治療選択肢について先週から悶々と考えていたのだけれども、一応最新のレビューではARはどちらかというと予後良好因子でER陽性症例ではERと競合することになってる https://t.co/CXnZmjg3ab

07 Oct 2020

Reply Repost Favourite

New Research: Androgen Receptor in Breast Cancer: From Bench to Bedside: Breast cancer (BC) is one of the most common malignancies and the leading cause of cancer-related mortality in women. Androgen receptor (AR) is frequently… https://t.co/VfCxd1WsRB #En

05 Sep 2020

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.